Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. [electronic resource]
Producer: 20060425Description: 1569-80 p. digitalISSN:- 0008-543X
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Burkitt Lymphoma -- drug therapy
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Dexamethasone -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Immunotherapy
- Infusions, Intravenous
- Male
- Middle Aged
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Rituximab
- Survival Analysis
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.